Cuba aims to vaccinate its entire population with a self-produced vaccine that is now in the second phase of testing.
Cuba’s vaccine institute, the Finlay Institute, has the capacity to produce 100 million doses of the Soberana 2 vaccine if the vaccine is approved, according to Vicente Verez.
The Soberana 2 vaccine is Cuba’s most advanced vaccine candidate out of several candidates that are under development.
If the phase two testing proves to be successful, the vaccine will move onto phase three, with 150,000 volunteers in March.
A total of 19,000 infected and 180 dead have been registered in Cuba, a country with 11 million inhabitants.
Cuba has a lot of experience with vaccines and produces 80% of the vaccines it needs, according to Jose Moya of the World Health Organization (WHO).
Source: #Norway Today, #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at email@example.com